ES2037086T3 - Procedimiento para preparar formulaciones farmaceuticas. - Google Patents
Procedimiento para preparar formulaciones farmaceuticas.Info
- Publication number
- ES2037086T3 ES2037086T3 ES198787306731T ES87306731T ES2037086T3 ES 2037086 T3 ES2037086 T3 ES 2037086T3 ES 198787306731 T ES198787306731 T ES 198787306731T ES 87306731 T ES87306731 T ES 87306731T ES 2037086 T3 ES2037086 T3 ES 2037086T3
- Authority
- ES
- Spain
- Prior art keywords
- procedure
- pharmaceutical formulations
- preparing pharmaceutical
- present
- cimetidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- CCGSUNCLSOWKJO-UHFFFAOYSA-N cimetidine Chemical compound N#CNC(=N/C)\NCCSCC1=NC=N[C]1C CCGSUNCLSOWKJO-UHFFFAOYSA-N 0.000 abstract 2
- 229960001380 cimetidine Drugs 0.000 abstract 2
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 229940124531 pharmaceutical excipient Drugs 0.000 abstract 1
- 239000000375 suspending agent Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
LA PRESENTE INVENCION PROPORCIONA UNA COMPOSICION FARMACEUTICA ESTABLE, ADECUADA PARA LA ADMINISTRACION ORAL, QUE CONSTA DE UNA SUSPENSION DE CIMETIDINA PARTICULADA EN UNA FASE ACUOSA, Y UN AGENTE SUSPENDEDOR, EN LA QUE PRACTICAMENTE TODA LA CIMETIDINA PRESENTE ES DE LA FORMA POLIMORFICA B, Y OPCIONALMENTE CUALQUIER OTRO EXCIPIENTE FARMACEUTICO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868618847A GB8618847D0 (en) | 1986-08-01 | 1986-08-01 | Pharmaceutical formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2037086T3 true ES2037086T3 (es) | 1993-06-16 |
Family
ID=10602097
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES198787306731T Expired - Lifetime ES2037086T3 (es) | 1986-08-01 | 1987-07-29 | Procedimiento para preparar formulaciones farmaceuticas. |
Country Status (22)
Country | Link |
---|---|
US (1) | US4996222A (es) |
EP (1) | EP0257823B1 (es) |
JP (1) | JPH0643304B2 (es) |
KR (1) | KR960012397B1 (es) |
CN (1) | CN1024497C (es) |
AU (1) | AU601206B2 (es) |
CA (1) | CA1287802C (es) |
DE (1) | DE3778795D1 (es) |
DK (1) | DK149988D0 (es) |
EG (1) | EG18388A (es) |
ES (1) | ES2037086T3 (es) |
GB (1) | GB8618847D0 (es) |
GR (1) | GR3005298T3 (es) |
HU (1) | HU205853B (es) |
IE (1) | IE60759B1 (es) |
IL (1) | IL83349A (es) |
MY (1) | MY100998A (es) |
PH (1) | PH23505A (es) |
PT (1) | PT85468B (es) |
WO (1) | WO1988000825A1 (es) |
ZA (1) | ZA875631B (es) |
ZW (1) | ZW13587A1 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HU196775B (en) * | 1986-08-05 | 1989-01-30 | Richter Gedeon Vegyeszet | Process for production of morfologically unique new modifications of famotidin and medical compositions containing such substances |
CH679373A5 (es) * | 1988-09-20 | 1992-02-14 | Glaxo Group Ltd | |
GB9127150D0 (en) * | 1991-12-20 | 1992-02-19 | Smithkline Beecham Plc | Novel treatment |
US5272137A (en) * | 1992-02-14 | 1993-12-21 | Mcneil-Pfc, Inc. | Aqueous pharmaceutical suspension for pharmaceutical actives |
FI941777A (fi) * | 1993-04-16 | 1994-10-17 | Mcneil Ppc Inc | Vesipitoinen farmaseuttinen suspensio ja menetelmä sen valmistamiseksi |
CA2172807C (en) * | 1994-08-01 | 1999-10-12 | Keith S. Lienhop | Tastemasked liquid pharmaceutical delivery system |
GB2298365B (en) * | 1995-03-03 | 1997-05-07 | Reckitt & Colmann Prod Ltd | A liquid pharmaceutical composition alginate and potassium bicarbonate |
GB9504599D0 (en) * | 1995-03-03 | 1995-04-26 | Reckitt & Colmann Prod Ltd | Improvements in or relating to organic compositions |
GB9708772D0 (en) * | 1997-04-30 | 1997-06-25 | Reckitt & Colmann Prod Ltd | Organic compositions |
CA2288743C (en) * | 1997-04-30 | 2008-04-22 | Reckitt & Colman Products Limited | Pourable alginate compositions |
IN186245B (es) | 1997-09-19 | 2001-07-14 | Ranbaxy Lab Ltd | |
US6287693B1 (en) | 1998-02-25 | 2001-09-11 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
US6132758A (en) * | 1998-06-01 | 2000-10-17 | Schering Corporation | Stabilized antihistamine syrup |
GB9930058D0 (en) | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
US6515008B1 (en) * | 2000-05-04 | 2003-02-04 | Smithkline Beecham Corporation | Formulation |
DE10224086A1 (de) * | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
US6930119B2 (en) * | 2002-07-17 | 2005-08-16 | Reliant Pharmaceuticals, Inc. | Liquid pharmaceutical composition |
US20050008660A1 (en) * | 2003-03-10 | 2005-01-13 | The Regents Of The University Of Michigan | Compositions and methods for use of alginate dural sealants |
EP1811854A1 (en) * | 2004-11-02 | 2007-08-01 | PURAC Biochem BV | Method for stabilizing and preventing coagulation of proteins in milk |
US20060094760A1 (en) * | 2004-11-04 | 2006-05-04 | Fawzy Abdel A | Composition, system and method of treatment of gastrointestinal disorders with nizatidine oral solution |
DE602005007205D1 (de) * | 2005-07-19 | 2008-07-10 | Ethypharm Sa | Gastroretentive Zusammensetzungen und Verfahren zur Herstellung |
FR2911506B1 (fr) * | 2007-01-18 | 2009-07-03 | Ceva Sante Animale Sa | Compositions pharmaceutiques destinees a une administration par voie orale sous forme de suspensions aqueuses stabilisees |
US8999395B2 (en) * | 2007-02-09 | 2015-04-07 | Ceva Sante Animale | Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions |
AU2010293105A1 (en) * | 2009-09-10 | 2012-04-05 | Bial - Portela & C.A., S.A. | Oral suspension formulations of esclicarbazepine acetate |
WO2018075801A1 (en) * | 2016-10-19 | 2018-04-26 | Signpath Pharma, Inc. | Protective effect of dmpc, dmpg, dmpc/dmpg, egpg, lysopg and lysopc against drugs that cause channelopathies |
GB201918617D0 (en) * | 2019-12-17 | 2020-01-29 | Reckitt Benckiser Health Ltd | Personal lubricant composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56104868A (en) * | 1980-01-24 | 1981-08-20 | Fujimoto Seiyaku Kk | Conversion between polymorphous crystals of cimetidine |
HU185457B (en) * | 1981-09-25 | 1985-02-28 | Richter Gedeon Vegyeszet | Process for preparating cimetidine-z |
CA1239349A (en) * | 1983-10-10 | 1988-07-19 | Eberhard F. Gottwald | Pharmaceutical composition containing cimetidine |
-
1986
- 1986-08-01 GB GB868618847A patent/GB8618847D0/en active Pending
-
1987
- 1987-07-22 ZW ZW135/87A patent/ZW13587A1/xx unknown
- 1987-07-27 CA CA000543046A patent/CA1287802C/en not_active Expired - Lifetime
- 1987-07-27 IL IL83349A patent/IL83349A/xx not_active IP Right Cessation
- 1987-07-27 MY MYPI87001138A patent/MY100998A/en unknown
- 1987-07-28 PH PH35588A patent/PH23505A/en unknown
- 1987-07-29 EP EP87306731A patent/EP0257823B1/en not_active Expired - Lifetime
- 1987-07-29 DE DE8787306731T patent/DE3778795D1/de not_active Expired - Lifetime
- 1987-07-29 ES ES198787306731T patent/ES2037086T3/es not_active Expired - Lifetime
- 1987-07-29 AU AU77564/87A patent/AU601206B2/en not_active Expired
- 1987-07-29 JP JP62504716A patent/JPH0643304B2/ja not_active Expired - Lifetime
- 1987-07-29 HU HU874205A patent/HU205853B/hu unknown
- 1987-07-29 KR KR1019880700331A patent/KR960012397B1/ko not_active IP Right Cessation
- 1987-07-29 WO PCT/GB1987/000539 patent/WO1988000825A1/en unknown
- 1987-07-30 ZA ZA875631A patent/ZA875631B/xx unknown
- 1987-07-30 EG EG439/87A patent/EG18388A/xx active
- 1987-07-31 PT PT85468A patent/PT85468B/pt unknown
- 1987-07-31 CN CN87105387A patent/CN1024497C/zh not_active Expired - Lifetime
- 1987-07-31 IE IE207787A patent/IE60759B1/en not_active IP Right Cessation
-
1988
- 1988-03-18 DK DK149988A patent/DK149988D0/da not_active Application Discontinuation
-
1990
- 1990-03-09 US US07/490,851 patent/US4996222A/en not_active Expired - Lifetime
-
1992
- 1992-07-29 GR GR920401630T patent/GR3005298T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
PT85468A (en) | 1987-08-01 |
DK149988A (da) | 1988-03-18 |
IE60759B1 (en) | 1994-08-10 |
CA1287802C (en) | 1991-08-20 |
ZW13587A1 (en) | 1989-02-15 |
JPH0643304B2 (ja) | 1994-06-08 |
PT85468B (pt) | 1990-06-29 |
GR3005298T3 (es) | 1993-05-24 |
DK149988D0 (da) | 1988-03-18 |
GB8618847D0 (en) | 1986-09-10 |
IE872077L (en) | 1988-02-01 |
KR960012397B1 (ko) | 1996-09-20 |
AU7756487A (en) | 1988-02-24 |
EG18388A (en) | 1992-10-30 |
AU601206B2 (en) | 1990-09-06 |
MY100998A (en) | 1991-06-29 |
DE3778795D1 (de) | 1992-06-11 |
CN1024497C (zh) | 1994-05-18 |
WO1988000825A1 (en) | 1988-02-11 |
EP0257823A1 (en) | 1988-03-02 |
CN87105387A (zh) | 1988-02-17 |
PH23505A (en) | 1989-08-16 |
JPH01500434A (ja) | 1989-02-16 |
HUT46541A (en) | 1988-11-28 |
EP0257823B1 (en) | 1992-05-06 |
HU205853B (en) | 1992-07-28 |
KR880701551A (ko) | 1988-11-03 |
IL83349A (en) | 1992-03-29 |
US4996222A (en) | 1991-02-26 |
ZA875631B (en) | 1989-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2037086T3 (es) | Procedimiento para preparar formulaciones farmaceuticas. | |
CS653586A3 (en) | Pharmaceutical containing 7-isopropoxyisoflavone | |
ES2074124T5 (es) | Composicion en forma de una espuma que contiene acido 5-aminosalicilico para administracion intra-rectal. | |
ZA888461B (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
ES2139132T3 (es) | Composiciones farmaceuticas activas en la terapia de desordenes del sueño. | |
IL80149A (en) | Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases | |
JO1502B1 (en) | New pharmacy vehicles | |
ES2040727T3 (es) | Un proceso para preparar una formulacion en aerosol en solucion de un analogo. | |
ES2040232T3 (es) | Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina. | |
ES2052603T3 (es) | Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen. | |
PT98371A (pt) | Processo para a preparacao de derivados 6-alcoxi de arabinofuranosil-guanina e de composicoes farmaceuticas que os contem | |
ES2062610T3 (es) | Compuesto diarilico anti-ateroesclerotico. | |
EP0282818A3 (en) | The use of gepirone for preparing a pharmaceutical composition for alleviation of primary depressive disorders | |
ATE99945T1 (de) | Verwendung von 5'-deoxy-5'-methylthioadenosin s- adenosylmethionin und dessen salzen zur herstellung von seborrhea vermindernden arzneimitteln. | |
GB2021409A (en) | Pharmaceutical composition | |
ES2160582T3 (es) | Capsula dura de ocfosfato de citarabina. | |
MY101916A (en) | Etoposide oral dosage form. | |
GB1480441A (en) | Compositions for treating nicotine poisoning | |
IT8567725A0 (it) | Li contengono derivati 1-sostituiti del 4-metossi-2,3,6-trimetilbenzene loro procedimento di preparazione e composizioni medicamentose e cosmetiche che | |
IT8521528A0 (it) | Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo. | |
JPS6438073A (en) | Novel derivative of tetrahydropyridine, manufacture and intermediate, use as drug and medicinal composition | |
ES2016052A6 (es) | Procedimiento para preparar derivados de adenosinmonofosfonato (amp) ciclico y de guanosinmonofosfonato (gmp) ciclico. | |
DE3579074D1 (de) | Verminderung der toxischen wirkungen von anthrachinon-medikamenten. | |
MX174642B (es) | Formulaciones farmaceuticas | |
FR2453153A1 (fr) | Nouveau derive de dehydroproline, sa preparation et son application comme medicament |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 257823 Country of ref document: ES |